Mainz Biomed BV (MYNZ) — Net Asset Quality Index
Mainz Biomed BV (MYNZ) has a Net Asset Quality Index of 12.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $5.33 Million minus total liabilities of $4.69 Million yields net assets of $641.60K. A higher index indicates a stronger, lower-leverage balance sheet. Read MYNZ total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Mainz Biomed BV Net Asset Quality Index Over Time (2019–2025)
This chart shows how Mainz Biomed BV's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the index stands at 12.0%, representing net assets of $641.60K against total assets of $5.33 Million USD. For live market cap and overall valuation, see Mainz Biomed BV (MYNZ) market capitalisation.
Annual Net Asset Quality Index for Mainz Biomed BV (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Mainz Biomed BV from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check MYNZ strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 12.0% | $641.60K | $5.33 Million | $4.69 Million | ▼ -33.6 pp |
| 2024 | 45.7% | $6.05 Million | $13.24 Million | $7.19 Million | ▲ +24.6 pp |
| 2023 | 21.1% | $3.25 Million | $15.41 Million | $12.16 Million | ▼ -48.6 pp |
| 2022 | 69.6% | $14.10 Million | $20.24 Million | $6.14 Million | ▲ +6.3 pp |
| 2021 | 63.4% | $6.36 Million | $10.04 Million | $3.68 Million | ▲ +470.6 pp |
| 2020 | -407.2% | $-2.74 Million | $673.27K | $3.41 Million | ▼ -134.8 pp |
| 2019 | -272.4% | $-1.95 Million | $715.96K | $2.67 Million | — |